Unlock instant, AI-driven research and patent intelligence for your innovation.

Carboxamide and sulfonamide derivatives useful as tead modulators

A compound and alkyl technology, which is applied in the preparation of carboxylic acid amides, sulfonamides, drug combinations, etc., can solve problems such as protein instability

Pending Publication Date: 2021-05-14
F HOFFMANN LA ROCHE & CO AG
View PDF102 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Additionally, phosphorylation of YAP and TAZ is believed to destabilize these proteins by activating phosphorylation-dependent degradation catalyzed by YAP or TAZ ubiquitination

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carboxamide and sulfonamide derivatives useful as tead modulators
  • Carboxamide and sulfonamide derivatives useful as tead modulators
  • Carboxamide and sulfonamide derivatives useful as tead modulators

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0424] Preparation of N-(3-(2-cyclohexylcyclopropyl)-4-methoxyphenyl)methanesulfonamide (enantiomer A and enantiomer B)

[0425] The reaction scheme is as follows:

[0426]

[0427] Step 1: N-(3-Bromo-4-methoxyphenyl)methanesulfonamide

[0428] Charge 2-bromo-4-iodoanisole (1.0g, 3.0mmol), methanesulfonamide (1.4g, 15mmol), cuprous iodide (590mg, 3.03mmol), N,N-dimethyl Glycine (319 mg, 3.03 mmol) and tripotassium phosphate (1.3 g, 6.1 mmol), and the flask was purged with nitrogen. N,N-Dimethylglycine (10 mL) was then added, and the reaction was stirred at 100°C for 2 hours. The reaction mixture was diluted with water (10 mL) and 10% aqueous glycine (10 mL), acidified with 1N HCl to pH = 1, extracted with i-PrOAc (3x10 mL), washed with anhydrous MgSO 4 Drying, concentration and purification by silica gel column chromatography (0% to 100% i-PrOAc in heptane) afforded the title compound as a white solid (598 mg, 70% yield). LCMS(ESI+)m / z280(M+H) + .

[0429] Step 2: (E)...

example 2

[0436] (E)-N-(3-(2-(4,4-difluorocyclohexyl)vinyl)-4-methoxyphenyl)methanesulfonamide)

[0437] The reaction scheme is as follows:

[0438]

[0439] Step 1: Diethyl (2-methoxy-5-(methylsulfonamido)benzyl)phosphonate

[0440] 2-(diethoxyphosphorylmethyl)-4-iodo-1-methoxybenzene (5.0g, 13mmol), tert-butyl n-methylsulfonylcarbamate (7.1g, 36mmol), cuprous iodide (2.5g, 13mmol), N,N-dimethylglycine (1.4g, 13mmol) and tripotassium phosphate (11.4g, 52.1mmol), and purged the flask with nitrogen. N,N-Dimethylacetamide (43 mL) was then added and the flask was flushed with nitrogen again and an air balloon was placed on top of the reaction vessel to allow room for gas evolution. The reaction mixture was stirred at 110°C for 16 hours. The resulting mixture was diluted with 10% aqueous glycine and acidified to pH 1 with 1N HCl, extracted with dichloromethane (3x50 mL), washed with anhydrous MgSO 4 Drying, concentration under reduced pressure and purification by silica gel column ch...

example 3

[0444] (E)-N-(3-(2-cyclopentylvinyl)-4-methoxyphenyl)methanesulfonamide

[0445]

[0446] The title compound (14 mg, 38% yield) was prepared according to the procedure of Example 2 using cyclopentanaldehyde. 1 H NMR (400MHz, DMSO-d 6 )δ9.27(s,1H),7.26(d,J=2.6Hz,1H),7.06(dd,J=8.8,2.6Hz,1H),6.95(d,J=8.8Hz,1H),6.57( dd,J=16.0,1.1Hz,1H),6.14(dd,J=16.0,7.9Hz,1H),3.77(s,3H),2.88(s,3H),2.64–2.54(m,1H),1.89 –1.75(m,2H),1.75–1.50(m,4H),1.43–1.27(m,2H); LCMS(ESI+)m / z 296.1(M+H) + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention is concerned with the compounds of formula (I) and formula (II): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of using the compounds of formula (I) and formula (II) as well as pharmaceutical compositions containing such compounds. The compounds are useful in treating diseases and conditions mediated by TEAD, such as cancer.

Description

[0001] sequence listing [0002] This application contains a Sequence Listing, which has been filed electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy was created on August 30, 2019, named 33988-185_ST25, and is 34KB in size. [0003] Cross references to related patent applications [0004] This application claims the benefit of priority to PCT / CN2018 / 103789, filed September 3, 2018, and PCT / CN2018 / 116897, filed November 22, 2018, both of which are incorporated herein by reference in their entirety. technical field [0005] The present disclosure relates to organic compounds of formula (I) and formula (II), which are useful in the treatment and / or prophylaxis of mammals, in particular as inhibitors of TEAD useful in the treatment of cancer. Background technique [0006] The Hippo pathway is a signaling pathway that regulates cell proliferation and cell death and determines organ size. This pathway is believed to functio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C233/65C07C311/08C07C311/14C07D209/08A61P35/00C07D209/10C07D213/76C07D213/81C07D213/82C07D237/22C07D237/24A61K31/44
CPCC07C311/08C07C311/14C07D213/76C07D213/82C07D213/81C07D237/22C07D237/24C07D209/08C07D209/10A61P35/00C07C311/12C07C311/13C07C235/46C07C235/48C07C231/14C07C303/40
Inventor C·坎宁安P·P·贝罗扎J·J·克劳福德W·李O·雷内J·R·兹比埃格廖江鹏王弢余辰
Owner F HOFFMANN LA ROCHE & CO AG